Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: A new highly active chemotherapeutic regimen

Annals of Oncology

Volumn 12, Issue 6, 2001, Pages 767-772

  Gebbia, V ^a,b   Testa, A ^b   Borsellino, N ^b   Ferrera, P ^b   Tirrito, M ^c   Palmeri, S ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b LA MADDALENA CANCER CENTER   (Italy)

^c NONE

Author keywords

Cisplatin; Endometrial carcinoma; Vinorelbine

Indexed keywords

CISPLATIN; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; BOLUS INJECTION; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; LEUKOPENIA; METASTASIS; NEUROTOXICITY; PAIN; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; STOMATITIS; SURVIVAL TIME; VOMITING;

ADENOCARCINOMA; ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; SURVIVAL RATE; TIME FACTORS; VINBLASTINE;

EID: 0034954218     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011160110205     Document Type: Article

References (30)

1. Risk factors, epidemiology, screening, and prognostic factors in female genital cancer
2. Reproductive factors and risk of endometrial cancer
3. Systemic treatment of advanced and recurrent endometrial carcinoma: Current status and future directions
4. Systemic therapy for gynecological cancer
5. Advances in the chemotherapy of gynecological cancer
6. Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: A gynecologic oncology group study
7. Comparison of adriamycin with cyclophosphamide in patients with advanced endometrial cancer
8. Phase II evaluation of epirubicin (E) in advanced endometrial carcinoma
9. Treatment of advanced endometrial adenocarcinoma with cis-dichlorodiammine platinum (II) after intensive prior therapy
10. Phase II evaluation of carboplatin in advanced endometrial carcinoma
11. A randomized comparison of adriamycin with or without cyclophosphamide in the treatment of advanced or recurrent endometrial carcinoma
12. A phase II study of ifosfamide in endometrial cancer
13. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide
14. Treatment of advanced and recurrent endometrial cancer with cisplatin, doxorubicin, and cyclophosphamide
15. Phase II trial of cisplatin, adriamycin and etoposide for metastatic endometrial adenocarcinoma
16. Phase III trial of doxorubicin with or without cisplatin in advanced or recurrent endometrial carcinoma: A gynecologic oncology group study
17. A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: A gynecologic oncology group study
18. A trial of outpatient paclitaxel and carboplatin for advanced, recurrent, and histological high-risk endometrial carcinoma: Preliminary report
19. Vinorelbine: An overview
20. Phase II trial of weekly intravenous vinorelbine on first line advanced breast cancer chemotherapy
21. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non small cell lung cancer
22. Vinorelbine plus cisplatin for the treatment of stage IIIB and IV non-small cell lung cancer
23. A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck
24. Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin and 5-fluorouracil: A multicenter phase II trial
25. Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck
26. Phase II study vinorelbine in advanced squamous cell carcinoma of the uterine cervix (SCC): Preliminary results
27. Reporting results of cancer treatment
28. Nonparametric estimation from incomplete observations
29. The determination of the number of patients required in a preliminary trial and a follow-up trial of a new chemotherapeutic agent
30. Phase II study of cisplatin and vinorelbine as first-line chemotherapy of patients with carcinoma of the uterine cervix